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los Huesos (‘Pit of the bones’), which is 
where most of the fossils with claimed 
Neanderthal affinities come from. The 
more than 6000 fossils from that site 
show distinctive Neanderthal features, 
but have often been included in the 
H. heidelbergensis taxon because of 
their supposed great age (up to 600 ka). 
Further research has now suggested 
that the material looks too Neanderthal 
and is too young (~400 ka) to represent 
H. heidelbergensis, making these 
fossils early Neanderthals instead. 
However, adding extra complexity, 
recent findings reveal the Sima people’s 
mitochondrial DNA to be more similar to 
that of the Denisovans (see below) than 
Neanderthals. 
Are they our ancestors? African 
H. heidelbergensis material, such 
as Broken Hill, shares numerous 
features with European fossils such 
as Petralona, leading many to group 
them together. As long as Mauer is 
also included, this taxon can be named 
H. heidelbergensis. Proponents of this 
wide concept of H. heidelbergensis 
assert that the mosaic of primitive and 
derived features shared by this group of 
fossils is unique, with few traits linking 
them exclusively to either modern 
humans or Neanderthals (Figure 1B). 
H. heidelbergensis is thus hypothesised 
to be the last common ancestor of both 
Neanderthals in Eurasia and H. sapiens 
in Africa. This scenario is probably the 
most popular and well supported at 
present.
Why does it matter? Modern 
humans and Neanderthals show 
clear behavioural and morphological 
differences from each other, but also 
clear similarities. Determining the 
tempo and mode of the evolution 
of their distinct features requires an 
estimate for the divergence date of 
their lineages from the last common 
ancestor, while assessing the extent 
of behavioural and morphological 
features that may have evolved 
in parallel (e.g. burial of the dead, 
neurocranial expansion) requires 
knowledge of those features in the 
LCA. As yet, no H. heidelbergensis 
DNA has been sequenced, so the 
species cannot be recognised 
genetically, but by comparing 
genetic data from Neanderthals and 
H. sapiens it is possible to estimate 
a hypothetical divergence date 
(~410–440 ka) for the two species, 
based on mitochondrial DNA, providing 
calibration for the putative transition 
from H. heidelbergensis to its daughter 
species. If we know when and where 
we diverged from our closest relatives, 
we also have a better chance of 
inferring the selective pressures behind 
the origin of our species, finding out 
why populations of H. heidelbergensis 
separated and evolved into H. sapiens 
and Neanderthals.
You mentioned Denisovans. Could 
they be H. heidelbergensis or 
its descendants?  In 2010, DNA 
sequenced from a fossil finger bone 
in Siberia showed the existence of 
an unexpected additional human 
population in the late Pleistocene. This 
group was christened the ‘Denisovans’ 
after the site of Denisova Cave. We 
still don’t know what the Denisovans 
looked like, or completely understand 
their position relative to other 
species, but genomic data suggest 
they are related to the Neanderthals 
(Figure 1A,B). However, evidence of 
interbreeding with recent H. sapiens 
in Southeast Asia shows that the 
Denisovans were once widespread 
in the region. As there are potential 
H. heidelbergensis fossils from Asia, 
it is possible they could represent the 
ancestors of the Denisovans. Recent 
advances in ancient DNA extraction 
and processing mean that recovering 
diagnostic genetic material from 
mid-Pleistocene fossils such as the 
remains from Asia is now an exciting 
possibility. The geographic origin of 
H. heidelbergensis is still unknown, but 
the early fossils from Asia suggest that 
continent is as likely a place of origin 
as Europe or Africa at the moment. 
An Asian origin for a species directly 
ancestral to our own would certainly 
shake up the current rather Afro-centric 
view of our evolution. 
Where can I find out more?
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Ubiquitin, a 76 amino-acid polypeptide, 
presents a compact three-dimensional 
structure, utilising a fold that recurs 
within larger polypeptides and in 
other protein modifiers, such as 
NEDD8 and SUMO. Ubiquitylation 
was initially recognised as a signal for 
proteasome-mediated degradation. We 
shall consider here how this view has 
evolved to appreciate that the dynamic 
appendage of different types of 
ubiquitin chains represents a versatile, 
three-dimensional code, fundamental to 
the control of many cellular processes.
Ubiquitin is produced by four distinct 
genes: two of these, UBA52 and 
RPS27a, encode a single copy fused to 
ribosomal subunits, whereas the other 
two, UbB and UbC, are polyubiquitin 
genes encoding three and nine head-
to-tail repeats of ubiquitin, respectively. 
Free ubiquitin is cleaved from these 
gene products by peptidases that 
belong to the deubiquitylating family 
of enzymes (DUBs). UbC may make 
the major contribution to steady 
levels of ubiquitin, given that murine 
embryonic fibroblasts lacking Ubc have 
40% lower levels of ubiquitin, despite 
compensatory upregulation of the 
UbB transcript. Total ubiquitin levels in 
human embryonic kidney HEK293 cells 
have been estimated as 8 x 107 copies 
per cell (85 µM, 0.42% w/w protein), 
with ‘free’ ubiquitin being a fraction 
(23%) of this pool.
Ubiquitylation principally occurs 
at lysine residues of substrate 
proteins, creating an isopeptide bond. 
Monoubiquitylation accounts for the 
majority of substrate-conjugated 
ubiquitin in HEK293 cells (~63% of the 
total ubiquitin pool, of which about 
half is present in a histone-enriched 
fraction; Figure 1A). However, ubiquitin 
itself contains seven internal lysine 
residues — at positions 6, 11, 27, 29, 
33, 48, 63 — that allow for chains of 
ubiquitin to be formed by processive 
ubiquitylation events (~11% of the total 
ubiquitin pool in HEK293 cells). The 
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Figure 1. Analysis of ubiquitin (Ub) pools and chain linkage type.
(A) (i) Estimates of ubiquitin pools in HEK293 cells. Using a variety of strategies to isolate
the different pools of cellular ubiquitin, Kaiser et al. were able to apply mass spectrometry to
measure their relative sizes. Note that ‘free’ ubiquitin measured in these studies also includes
activated ubiquitin (thioester-linked), which is typically 30–50% of the total ‘free’ pool. Using
the approach indicated in (C), Peng and colleagues have obtained estimates of the prevalence
of particular ubiquitin chain Lys-linkage types within the polyubiquitin fraction in (ii) HEK293
and (iii) Saccharomyces cerevisiae (using cells expressing His-tagged Ub). (B) Eight varieties
of ubiquitin chain linkages, with distinct topologies, occur within the cell. Seven of these are
linked through isopeptide bonds between the carboxyl terminus and specific lysine (K) resi-
dues on ubiquitin. The other is a linear ubiquitin chain, which is linked through a peptide bond
with the amino-terminal methionine (M1). (C) Trypsin cleaves carboxy-terminally to basic resi-
dues, and the last four residues of ubiquitin are Leu–Arg–Gly–Gly. Digestion of ubiquitin chains
with trypsin therefore generates a diGly carboxy-terminal remnant linked through an isopeptide
bond to a linear peptide sequence, specific to the flanking sequences of each lysine in ubiq-
uitin. These peptides are quantified by mass spectrometry using comparison with isotopically
labelled peptide standards (Absolute QUAntification (AQUA) peptides), which are spiked into
the sample. This technique has been used to generate the data shown in (Aii) and (Aiii). (D
Chain-linkage types that are appended to individual proteins of interest can be assessed us-
ing a ubiquitin chain restriction digest. Immunoblotting using anti-ubiquitin antibodies reveals
changes in the higher molecular weight smear or ladder above the parental protein, which
represents the polyubiquitylated forms. The collapse of this ladder is analysed following expo-
sure to a panel of DUB enzymes (here Otulin, AMSH, OTUB-1 and USP21) that have activities
specific for different chain types. representation of these individual chain 
types can vary significantly between 
cell types and species (Figure 1A). 
A dedicated apparatus also exists 
to generate linear chains of ubiquitin 
linked through peptide bonds between 
the amino and carboxyl termini of neighbouring ubiquitins. Polyubiquitin 
chains may be constituted from a 
single linkage type or from a mixture 
of linkages, which allows for chain 
branching. The relative abundance 
of each chain linkage type has been 
determined by mass spectrometry, through quantifying specific trypsin-
generated peptide signatures (Figure 
1B,C). Linkages through these different 
lysine residues vary the disposition of 
neighboring ubiquitin molecules with 
respect to each other, thereby offering 
specific combinations of available 
surfaces and orientations. This property 
is exploited by processing enzymes 
and by ubiquitin-binding proteins 
to obtain selectivity for particular 
linkage types. Thus, distinct chain 
types have been linked to specific 
steps in the choreography of complex 
cellular processes, such as cell-cycle 
regulation (Lys11) and DNA repair 
(Lys63). However, all chain linkages, 
with the probable exception of Lys63, 
may contribute to the proteasomal 
turnover of proteins, as judged by 
their pattern of accumulation upon 
proteasome inhibition and in vitro 
studies. Ubiquitylation resembles 
phosphorylation in scope, but 
glycosylation in complexity.
Generating the code on substrate 
proteins
Ubiquitylation results from an 
enzymatic cascade, drawn from a 
palette of enzymes with a distinct 
hierarchy: E1s (two family members, 
UBA1 and UBA6 in the human 
genome); E2s (~40 members); and 
>600 E3s, which belong to one of 
three families (HECT, RING and RING-
between-RING (RBR)). A small set 
of E3 RING proteins combine with 
any of seven cullin family members 
and a variety of adaptor proteins to 
create a diverse family of cullin–E3 
ligases. Recent proteomic studies, 
using an antibody that recognises 
diGly-modified Lys residues to enrich 
ubiquitylated peptides, confirm the 
presence of many thousands of 
ubiquitylated proteins in the cell at 
steady state (Figure 2). 
E1s utilise a sequence of reactions 
driven by ATP to generate a thioester 
linkage between the carboxyl terminus 
of ubiquitin and the E1 active-site 
cysteine (Figure 3A). A key feature is 
the generation of a ubiquitin carboxy-
terminal acyl-adenylate intermediate 
(Ub–AMP), which reacts with the 
cysteine. Subsequently, a second 
Ub–AMP is generated, which remains 
non-covalently bound to the enzyme 
and enhances efficiency. Structural 
rearrangements increase the affinity 
for E2 enzymes, facilitating ubiquitin 
transfer to the E2 active-site cysteine 
by a trans-thioesterification reaction. 
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Figure 2. Enrichment of diGly-modified peptides allows global ubiquitome profiling.
Trypsin digestion of complex protein mixtures will leave a diGly stump of the distal ubiquitin molecule, linked through an isopeptide bond to the 
lysine residue of any ubiquitylated peptide sequence. Introduction of monoclonal antibodies specific for this configuration of three amino acids 
has provided an enrichment strategy for ubiquitylated peptides and has allowed for the identification of thousands of ubiquitylated peptides 
by mass spectrometry.HECT and RBR E3s also possess an 
active-site cysteine, which is charged 
with ubiquitin that has been transferred 
from their cognate E2 enzyme, prior to 
substrate modification. A significant 
fraction of the so-called ‘free’ ubiquitin 
pool (30–50%) is in fact thioester-linked 
to ubiquitin ligases at steady state. This 
can be quantified by comparing the 
low molecular weight ubiquitin band 
on gels run under reducing and non-
reducing conditions.
RING E3 ligases, lacking a catalytic 
cysteine, represent the most abundant 
set of E3s and instead serve as scaffold
molecules, which also help align the 
E2–ubiquitin thioester bond for attack 
by the substrate lysine. The cullin E3 
ligases are only activated following 
NEDDylation (modification with the 
ubiquitin-like molecule NEDD8) of 
the cullin subunit. This results in a 
dramatic reorientation of the RING 
domain, bringing the associated E2 
adjacent to the substrate site. Large-
scale conformational changes are also 
intrinsic to HECT ligase function and to 
the regulation of certain RING proteins, 
such as c-Cbl. Both E2s and E3s have 
active roles in determining the chain 
topology — i.e. linkage type — and 
processivity of chain elongation. 
Ubiquitin chain formation can be 
broken down into two key steps: 
firstly, initiation via conjugation to 
the substrate of the first ubiquitin; 
and secondly, chain elongation. After 
ubiquitin is discharged from the E2, 
the E2 must dissociate from the E3 in 
order to be recharged with ubiquitin by 
an E1. This frequently results in simple 
monoubiquitylation of substrates.  
However, if the chain is to be extended, 
either the original charged E2–E3 
combination can be reconstituted or 
an alternative E2 can be recruited that 
specialises in this task and may restrict 
the repertoire of linkage types. For 
example, the Lys63- and Lys11-specific 
chain-elongating E2s, UBE2N-UBE2V1 
and UBE2S, respectively, are unable 
to initiate ubiquitin chains. The Lys11 
selectivity of UBE2S depends upon a 
specific substrate-assisted catalysis 
mechanism. Alignment of the active 
site with Lys11 of the acceptor 
ubiquitin, through transient electrostatic 
interactions, brings Glu34 of ubiquitin 
close to the E2 catalytic site, completing 
a competent catalytic centre.
As well as linkage type, chain length 
is another parameter that can be 
interpreted by cellular machineries. 
Chain length reflects the processivity of 
the reaction, defined as the number of 
ubiquitin molecules transferred during 
a single round of association of an E3 
ligase with a substrate. Early in vitro 
studies suggested that a minimal 
length of four Lys48-linked ubiquitin 
molecules is required for proteasomal 
degradation, and three Lys63-linked 
ubiquitin molecules are required for 
the efficient activation of retinoic acid 
inducible gene 1 (RIG1), a component 
of the innate immunity system. 
Reading the code
The concept of conserved ubiquitin-
binding domains (UBDs) was 
introduced by the discovery of the UBA 
domain in multiple proteins that had 
been linked to ubiquitylation, including 
the multifunctional protein p62, for which actual binding to ubiquitin was 
first demonstrated. There are now at 
least 20 recognised UBDs in the human 
genome contained within hundreds 
of proteins. This realisation has led 
to the appreciation of ubiquitylation 
as a critical means of regulating the 
formation of networks of protein 
interactions and the activity of these 
networks in space and time (Figure 
3B). Pioneering studies on the NFkB 
and DNA repair pathways implicated 
ubiquitin at the heart of these signaling 
cascades, and this finding is now 
mirrored in studies of further key 
signaling pathways (e.g. TGFb, Wnt, 
MAP kinase).
Ubiquitin has a hydrophobic 
patch centred around Ile44 which 
is recognised by the majority of 
ubiquitin-binding domains. However, 
other modes of binding have been 
characterised. For example, the 
ZnF-UBP domain, found in the DUB 
USP5, principally recognises the diGly 
carboxyl terminus of unanchored 
ubiquitin, and the UBAN motif of NFkB 
essential modulator (NEMO) requires 
an interaction with the linker region 
of Met1-linked linear ubiquitin chains. 
The affinity of UBDs for monoubiquitin 
is necessarily low (>100 µM) as ‘free’ 
ubiquitin itself is estimated to be in 
the 10–20 µM range. Avidity will be 
correspondingly higher for ubiquitin 
chains, due to the multiplicative 
effect of more than one binding site. 
According to the published structures, 
one might predict different levels of 
access to more compact ubiquitin chain 
configurations (e.g. Lys48) versus open 
structures (Lys63). However, some 
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Figure 3. Reading, writing and wiping the ubiquitin code. 
(A) The ubiquitylation cascade. An E1 is charged with ubiquitin (Ub) linked to the catalytic cysteine of E1 by a thioester bond. This leads to structural 
rearrangements that allow for association with E2 enzymes and the transfer of ubiquitin to E2. The charged E2 interacts with E3 ligases, which also 
recognise substrates. In the case of RING E3s, which simply act as scaffolds, ubiquitin is then directly transferred from the E2 to lysine residues on 
substrate proteins. For HECT and RING between RING (RBR) E3s, ubiquitin is transferred via the E3 itself following charging by the E2. Discharge of 
Ub from the E2 reduces the affinity of E2 for the E3, providing access for a newly charged E2 to extend a ubiquitin chain. The complement of ubiqui-
tin-modifying components in the human genome has a hierarchical structure, with substrate specificity provided by a large number of E3s (bottom). 
(B) Ubiquitylation is recognised by around 20 types of ubiquitin-binding domain (UBD), which allow the assembly of ubiquitin-dependent interaction 
networks. Tandem arrangements of UBDs or associations between UBD proteins produce specific geometries that allow selection for ubiquitin chain 
types (a–d), or coincidence detection of multi-monoubiquitylation ((i) and (ii)). UBD binding can also shift the dynamic equilibrium between open and 
closed states of certain ubiquitin chain types (iii). (C) Deubiquitylases (DUBs) process ubiquitin chains. In addition to chain-type selectivity as shown in 
Figure 1D, some DUBs recognise different positions in the ubiquitin chain (exopeptidase and endopeptidase activity). Exopeptidase activity, specific 
to the distal ubiquitin, regenerates free ubiquitin directly, whilst endopeptidase activity can also release short ubiquitin chains. Specific removal of 
chains en bloc may require recognition of the substrate protein. Enzymes restricted to specific types of ubiquitin-chain linkage will generate a monou-
biquitin stub, which can be removed by a more promiscuous enzyme or a substrate-selective DUB.types of ubiquitin chain are clearly in 
dynamic equilibrium between ‘open’ 
and ‘closed’ structures and can be 
stabilised in the open configuration by 
UBD binding. 
It seems most likely that the 
combinatorial use of UBDs dictates 
many aspects of ubiquitin chain 
specificity. Frequently, proteins 
possess tandem UBDs, allowing for 
‘linkage-specific avidity’ that relies 
on the detection of the distance 
between the individual molecules of 
a ubiquitin chain and the orientation 
of these molecules (Figure 3B). The 
DNA repair protein, Rap80 has tandem 
UIM domains separated by a seven 
amino-acid linker region, which creates the ideal distance for association with 
ubiquitin molecules spanning a Lys63 
linkage. A shorter linker between UIMs 
in ataxin-3 provides binding specificity 
for Lys48 linkages. Associations 
between UBD-containing proteins 
may provide even more versatility. 
For example, the ESCRT-0 complex 
comprising Hrs and STAM, which 
is involved in endosomal sorting of 
ubiquitylated receptors, presents 
five ubiquitin-binding sites on its 
surface. Multi-monoubiquitylated 
protein modules present similar 
opportunities for discrimination. 
Ubiquitylated proteins can also receive 
contemporaneous post-translational 
modifications, such as phosphorylation or acetylation. Binding can therefore be 
contingent on two signals, sometimes 
referred to as coincidence detection. 
Understanding the cross-talk between 
these types of signal is a rapidly 
expanding area.
One role of the interaction of 
UBDs with ubiquitin chains is to 
protect proteins from proteasomal 
degradation, and this may underly 
the privileged protection of Lys63 
chains. An interesting case is the 
yeast transcription factor Met4, which 
contains two UBDs that stabilise it in 
a Lys48-linked form, but restrict the 
linear growth of the polyubiquitin chain. 
Under certain growth conditions, this 
protection is removed and rapid chain 
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degradation.
Editing and wiping the code
A set of ~90 DUBs can cleave the 
ubiquitin isopeptide bond at the end of 
a chain (exopeptidase activity) or from 
within the polymer (endopeptidase 
activity), as shown in Figure 3C. This set 
of DUBs contains five distinct families, 
four belonging to the cysteine protease 
class (UCH, USP, OTU and Josephins), 
and the other being the JAMM/MPN+ 
family of metalloproteases. The cysteine 
proteases share a common catalytic 
triad (Cys–His–Asn/Asp), which must 
be properly aligned, in order to activate 
the cysteine for nucleophilic attack 
upon the peptide bond. Mirroring E2s, 
except with the opposite result, some 
DUBs will solely process specific chain 
linkages, such that they may edit the 
chain down to a monoubiquitylated 
stub, which a separate DUB may 
then cleave. Alternatively, the residual 
monoubiquitin may be extended 
once again either by the original or an 
alternative E2–E3 combination, which 
can lead to the generation of a new 
chain type at the same position (chain 
editing). It is common for DUBs and E3s 
to bind to each other, and the formation 
of such a complex may coordinate 
editing functions. Another view is that 
this reflects a separate major role of the 
DUBs: protecting E3s from their own 
tendency to autoubiquitylate and hence 
regulating their stability. An example of 
this is the association between USP7 
and the p53 regulator MDM2.
The most abundant DUB family 
are the USPs and these also exhibit 
the greatest array of accessory 
domains, consistent with a higher 
degree of selectivity at the protein 
substrate level. Accordingly, with the 
exception of CYLD, USPs show little 
selectivity between linkage types when 
presented with free ubiquitin chains. In 
contrast, several of the JAMM/MPN+ 
metalloproteases show stringent 
selectivity for Lys63-linked chains and 
have been implicated in the governance 
of endocytic trafficking (AMSH) and 
DNA repair (BRCC3) pathways. The 
OTU family is most fascinating from 
this point of view. Most OTUs prefer 
a restricted set of chain types, but 
the favored topologies vary greatly 
within the family: six of them are 
highly selective for an individual chain 
type, whilst a further four will cleave 
only two types of chain linkage. For 
example, three enzymes separately linked to the NFkB signaling pathway 
exclusively process in vitro either 
linear chains (Otulin), Lys11 chains 
(Cezanne) or Lys11 plus Lys48 (A20). 
These characteristics suggest that the 
OTUs may play prominent roles in chain 
editing and in regulating the global 
abundance of specific linkage types. 
This refinement of DUB selectivity 
profiles underpins a novel method 
for the interrogation of chain linkages 
associated with particular proteins. 
By assessing the impact of a panel of 
selective DUB enzymes upon the higher 
molecular weight ubiquitin species, 
a ‘restriction map’ can be generated 
(Figure 1D). Only the minor ubiquitin 
chain linkage species Lys27, Lys29 and 
Lys33 cannot be discriminated in this 
manner with the current tool set.
Structural, biochemical and modeling 
studies of the action of DUBs upon 
various types of di-ubiquitin (diUb) 
have revealed a number of distinct 
mechanisms by which DUBs achieve 
chain selectivity. DUBs can interact 
with sites in ubiquitin that are both 
amino-terminal (P1, P2...) and carboxy-
terminal (P1’, P2’....) to the scissile 
bond. The corresponding sites on the 
enzyme are referred to as S1 and S1’ 
etc. The distal ubiquitin, which binds 
to the S1 site so that the carboxy-
terminal tail sits in the catalytic site, is 
common to all diUb molecules. Chain 
specificity must therefore reside in 
the recognition and alignment of the 
proximal ubiquitin. An S1’ site specific 
to a restricted set of chain topologies 
can be provided by the catalytic 
domain of the DUB, or by an accessory 
UBD associated with the DUB itself 
(e.g. the UIM domain in OTUD1), or 
in principle by an interacting protein. 
Each lysine of ubiquitin is flanked by 
different peptide sequences that could 
be used for selection. In general, OTUs 
do not discriminate between synthetic 
ubiquitylated-ubiquitin peptides, except 
for OTUD2, which is selective for 
peptides comprising the Lys11 flanking 
sequence. However, some DUBs that 
cleave either monoubiquitin or chains 
en bloc from protein substrates are 
likely to recognise the flanking regions. 
The active-site histidine of the linear-
chain-specific DUB Otulin is misaligned 
for catalysis in the apo-enzyme. It is 
then aligned upon substrate binding, in 
part through interaction with the amino-
terminal methionine of the proximal 
ubiquitin that is linked by a peptide 
bond to the carboxy-terminal glycine 
of the distal ubiquitin. The apo form of USP7 also has a misaligned active site. 
Correct positioning of the active site 
histidine is required to lower the pKa 
of the active-site cysteine rendering it 
competent for the nucleophilic attack 
on the ubiquitin–isopeptide bond, 
but this also makes DUBs vulnerable 
to oxidation. It follows then, that 
misalignment in the apo form provides 
a means to protect certain DUBs from 
oxidation.
Housekeeping roles for UCH DUBs
The UCH DUB family consists of four 
members — UCHL1, UCHL3, UCHL5 
and BAP1. UCHL5 is a proteasome-
associated DUB, whilst BAP1 is a 
major tumor suppressor that has 
been associated with DNA repair 
pathways. UCHL1 and UCHL3 are 
intriguing members of the family that 
tend to be very highly expressed. For 
example, it has been estimated that 
UCHL1 may constitute as much as 
2.5% of brain protein. At such levels its 
ubiquitin-binding capacity may provide 
an effective buffer of free ubiquitin 
concentration. The activity of these 
enzymes is restricted by an obstruction 
at the catalytic site to favour small 
leaving groups appended to the 
carboxyl terminus of ubiquitin. UCHs 
may be well suited for processing the 
pro-ubiquitin gene products, which 
in most organisms contain head-to-
tail repeats of the ubiquitin sequence 
with an additional amino acid or 
short peptide capping the carboxyl 
terminus. All of the intermediates in the 
enzymatic activation of the ubiquitin 
carboxyl terminus are thioesters, 
which can form adventitious adducts 
by thiol or amine modification. In vitro 
data have led to the suggestion that, 
if left unchecked, this would rapidly 
deplete the free ubiquitin pool. Such 
adducts are processed efficiently by 
UCHL1/3 and this may represent the 
major physiological function of these 
particular DUBs.
Targeting the ubiquitin–proteasome 
system
There is a strong swell of interest in 
targeting the ubiquitin–proteasome 
system for therapeutic purposes. The 
proteasome inhibitor bortezomib has 
been used to treat tens of thousands of 
cancer patients. MLN-4924, an inhibitor 
that targets an E1 for the ubiquitin-like 
molecule NEDD8, also shows promise. 
Use of thalidomide as a treatment for 
multiple myeloma reflects its binding 
to cereblon, a component of a cullin 
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towards a waving bug leg. Motion-
oriented lures, in which a predator 
moves an existing or modified body 
part in such a predetermined manner 
are well documented in vertebrates 
[6]. However, until very recently, there 
had been no substantiated examples 
of invertebrates using such a strategy 
[8] and none until our example that 
targets another invertebrate. 
In stark contrast to all known 
lurers, the bug did not strike its 
ant-prey when the prey was in close 
proximity, touching the bug, or even if 
the ant momentarily grasped the bug 
(Figure 1C; n = 1235 interactions). 
Instead, the bug only attacked when 
the ant firmly grasped a bug’s hind 
leg and was either trying to sting or 
drag it (Supplemental movies). This 
trend remained even with the bugs 
at risk of starvation. Collected bugs 
starved for two weeks were placed in 
a 100 mm petri dish with an individual 
M. pilosula for 15 minutes. Even 
under these conditions the bugs still 
only attacked if an ant grasped a 
bug’s hind leg (N = 95; nattacks/grasps 
= 18/18; nattacks/no grasps = 0/77; 
c21 = 98.28; P << 0.001), and this 
was despite ants making numerous 
contacts with the bug prior to the 
attack (average = 38 ± 15 per trial). 
This departure from typical luring 
behaviour not only distinguishes 
feather-legged assasin bugs from 
other known lurers [5–8] but also from 
all documented predators [1]. With an 
ant still grasping a leg, the bug then 
lifted its body off the tree trunk and 
swivels up to 180o around its ‘knee’ 
joint to reposition its body above 
the ant. Here, the bug circumvented 
the hardened exoskeleton of the 
ant by piercing the indefensible 
intersegmental membrane just behind 
an ant’s head.
Once an ant grasped a bug’s hind 
leg, bugs had a surprisingly high 
capture success rate of 81% (Figure 
1B). However, this crucial part of the 
prey capture strategy is also a major 
constraint (Figure 1C). Only 2.5% of 
bug-ant encounters resulted in ants 
grabbing a bug hind leg (n = 31 out 
of 1235 interactions), suggesting little 
return from this predatory strategy. 
The rarity of the capture events 
though is likely to be offset by prey 
size. Ants that physically interacted 
with the bugs were on average 1.93 
± 0.98 (n = 81) times larger than the 
bug. In some cases the size difference 
between the bug and ant was so large 
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Predators use many different 
strategies to capture prey, including 
ambushing, active pursuit and 
luring [1]. No matter the strategy 
used, predators usually attempt 
to make the first physical contact 
with prey. This is not surprising, as 
prey, regardless how dangerous, 
can damage or kill a predator if they 
initiate contact with the predator 
[2,3]. Instead, predators typically 
minimise risk of harm using superior 
body size or offences to subdue 
prey before they can retaliate or 
escape [1,4]. Even the anglerfish that 
stimulates prey to attack its lure, 
intercepts the prey before substantial 
contact is made [5]. It would, 
therefore, seem counterintuitive for a 
predator to invite prey to physically 
assault them before the predator 
will strike. Yet, we here describe the 
predatory strategy of the nymphs 
of the ant-eating feather-legged 
assassin bug Ptilocnemus lemur 
that requires its often much larger 
predaceous ant-prey to grab the 
bugs’ hind legs before the nymph 
will attack. We propose that this 
unique physical predatory strategy 
is surprisingly effective in reducing 
the threat from a disproportionally 
dangerous prey animal.
The hind legs of Ptilocnemus 
lemur are covered by a brushlike 
cluster of setae (Figure 1A). Our 
natural experiments of bug nymphs 
on tree-trunks showed that they 
commence the predatory sequence 
by waving these hind legs (Figure 1B; 
Supplemental movies), stimulated 
by foraging ants moving within 5 cm 
of the bug (Nant-bug interactions = 2185; 
n<5cm = 973/1290; n>5cm = 104/895, 
c21 = 858.1; P << 0.001). The 
response of solitary ants, such as 
Myrmecia pilosula, to the waving leg 
was typical of prey responding to a 
lure [5–7]: the ants deviated from their 
foraging path and moved directly 
CorrespondencesE3 ligase complex. Thalidomide redirects the E3 ligase activity of this 
complex, inhibiting autoubiquitylation 
whilst augmenting ubiquitylation and 
degradation of the B-cell-specific 
transcription factors IKZF1/3. The 
next decade is likely to witness the 
development of drugs targeting 
ubiquitin ligases at all levels of the 
conjugation cascade, as well as DUBs, 
for use in many areas of medicine. In 
some cases, specific compounds have 
already been reported.  We expect this 
area to undergo rapid growth, reflecting 
the recent expansion in awareness of 
ubiquitylation as a major medium for 
intracellular communication.
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